Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011:2011:134295.
doi: 10.1155/2011/134295. Epub 2011 Apr 10.

Resolution of dialyzer membrane-associated thrombocytopenia with use of cellulose triacetate membrane: a case report

Affiliations
Case Reports

Resolution of dialyzer membrane-associated thrombocytopenia with use of cellulose triacetate membrane: a case report

Feyisayo Olafiranye et al. Case Rep Med. 2011.

Abstract

Blood and dialyzer membrane interaction can cause significant thrombocytopenia through the activation of complement system. The extent of this interaction determines the biocompatibility of the membrane. Although the newer synthetic membranes have been shown to have better biocompatibility profile than the cellulose-based membranes, little is known about the difference in biocompatibility between synthetic membrane and modified cellulose membrane. Herein, we report a case of a patient on hemodialysis who developed dialyzer-membrane-related thrombocytopenia with use of synthetic membrane (F200NR polysulfone). The diagnosis of dialyzer membrane-associated thrombocytopenia was suspected by the trend of platelet count before and after dialysis, and the absence of other possible causes of thrombocytopenia. We observed significant improvement in platelet count when the membrane was changed to modified cellulose membrane (cellulose triacetate). In patients at high risk for thrombocytopenia, the modified cellulose membrane could be a better alternative to the standard synthetic membranes during hemodialysis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The trend of platelet counts before and after hemodialysis with polysulfone (PS) and cellulose triacetate (CTA) dialyzer membrane.

References

    1. Harrison CN, Machin SJ. Thrombocytopenia. In: Webb AR, Shapiro MJ, Singer M, Suter PM, editors. Oxford Textbook of Critical Care. Oxford, UK: Oxford University Press; 1999. pp. 674–675.
    1. Mulder J, Tan HK, Bellomo R, Silverster W. Platelet loss across the hemofilter during continuous hemofiltration. International Journal of Artificial Organs. 2003;26(10):906–912. - PubMed
    1. Chenoweth DE. Complement activation in extracorporeal circuits. Annals of the New York Academy of Sciences. 1987;516:306–313. - PubMed
    1. Chenoweth DE, Henderson LW. Complement activation during hemodialysis: laboratory evaluation of hemodialyzers. Artificial Organs. 1987;11(2):155–162. - PubMed
    1. Sirolli V, Ballone E, Di Stante S, Amoroso L, Bonomini M. Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane. International Journal of Artificial Organs. 2002;25(6):529–537. - PubMed

Publication types

LinkOut - more resources